Showing results (1531-1540 of 10,441) with videos related to
Sort By:
Pageof 1,045
AIDS (London, England)|October 31, 2001
Replacing ritonavir by nelfinavir or nelfinavir/saquinavir as part of highly active antiretroviral therapy leads to an improvement of triglyceride levelsA M Wensing, M Reedijk, C Richter, et al.AIDS (London, England)|October 31, 2001
Reproductive behaviour of HIV-infected women living in France, according to geographical originF Fourquet, J Le Chenadec, M J Mayaux, et al.AIDS (London, England)|October 31, 2001
Mother-to-child discordance in HLA-G exon 2 is associated with a reduced risk of perinatal HIV-1 transmissionF O Aikhionbare, T Hodge, L Kuhn, et al.AIDS (London, England)|November 8, 2001
Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance developmentA N Phillips, M Youle, M Johnson, et al.AIDS (London, England)|November 8, 2001
Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicidesS Di Fabio, G Giannini, C Lapenta, et al.AIDS (London, England)|November 8, 2001
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapyT R Sterling, R E Chaisson, R D MooreAIDS (London, England)|November 8, 2001
Acute HIV infection: impact on the spread of HIV and transmission of drug resistanceS Yerly, S Vora, P Rizzardi, et al.AIDS (London, England)|February 24, 2001
Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytesT J Liegler, M S Hayden, K H Lee, et al.AIDS (London, England)|February 24, 2001
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA studyA Mocroft, A N Phillips, V Miller, et al.AIDS (London, England)|February 24, 2001
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adultsM A Quigley, A Mwinga, M Hosp, et al.Pageof 1,045